Page 23 - U.S. Growth Pharmaceuticals & Biotech Stocks

UPDATED Apr 12, 2026

Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

711 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
NBP
US$2.36-2.9%252.7%US$272.9mUS$8.251.2-14.3%n/a
MGNX
US$3.6017.3%179.1%US$228.8mUS$4.801.5-14.4%n/a
DRMA
US$1.22-5.4%-84.9%US$4.9mUS$4.000.8-14.5%n/a
TECX
US$30.720.7%90.1%US$576.8mUS$78.252.3-14.8%n/a
COCP
US$1.25-17.2%-2.3%US$17.2mUS$8.002.7-14.9%n/a
ELUT
US$1.13-3.4%-47.9%US$48.3mUS$5.003.9-14.9%n/a
BOLT
US$4.9114.5%-24.2%US$9.4mUS$29.001.2-15.2%n/a
NKTR
US$77.503.7%755.6%US$2.2bUS$128.1340.3-15.3%n/a
BBOT
US$8.40-5.7%-22.4%US$672.3mUS$25.381.6-15.3%n/a
RAPP
US$34.171.8%269.0%US$1.6bUS$53.603.4-15.4%n/a
CMMB
US$1.677.1%-60.9%US$12.0mUS$15.001.0-15.9%n/a
WHWK
US$3.39-3.4%106.7%US$160.0mUS$5.6722.4-16.1%n/a
TOVX
US$0.230.3%-79.8%US$10.6mUS$2.500.7-16.3%n/a
NNVC
US$0.985.6%-11.5%US$21.2mUS$6.501.9-16.4%n/a
SNSE
US$29.89-3.6%304.2%US$40.1mn/a2.2-16.4%n/a
VYNE
US$0.611.0%-65.1%US$20.3mUS$2.0035.7-16.6%n/a
ELDN
US$3.101.0%5.4%US$235.5mUS$8.001.7-16.7%n/a
GLUE
US$17.483.2%296.4%US$1.4bUS$32.1711.3-16.7%n/a
OVID
US$2.7525.0%882.1%US$362.7mUS$5.0150.0-17.0%n/a
ALLR
US$1.277.6%77.1%US$20.1mUS$9.7562.8-17.1%n/a
VERU
US$2.383.9%-56.1%US$38.2mUS$25.001.0-17.1%0%
SYRE
US$51.294.7%293.9%US$4.0bUS$64.367.2-17.9%n/a
AGMB
US$10.54-1.7%n/aUS$513.7mUS$32.00-6.1-18.0%n/a
TBPH
US$16.351.6%87.3%US$841.9mUS$17.208.0-18.3%n/a
Page 23 of 30